Sanofi India has received marketing approval from India's Central Drugs Standard Control Organization (CDSCO) for its diabetes drug Soliqua (in pre-filled pen). Soliqua is indicated as an adjunct treatment to improve glycemic control through diet and exercise in adults with obesity and type 2 diabetes who are inadequately controlled on...